This preliminary program is subject to change.

The Development of Peptide-Based Tools for the Analysis of Angiogenesis

Jeremy M. Murray1, Anna Fedorova2, Kerry Zobel2, Ping Wu1, Herman Gill3, Annie Ogasawara3, Judith Flores3, Jeff Tinianow3, Alexander Vanderbilt3, Gloria Meng4, Suzanna Clark5, SImon P Williams3, Jan Marik3, Deshayes Kurt2 and Christian Wiesmann6, (1)Structural Biology, Genentech, South San Francisco, CA, (2)Protein Engineering, Genentech, South San Francisco, CA, (3)Biomedical Imaging, Genentech, South San Francisco, CA, (4)Assay Technology, Genentech, South San Francisco, CA, (5)Cancer Signaling & Translational Oncology, Genentech, South San Francisco, CA, (6)Proteases and Structural Sciences, Novartis Institutes of BioMedical Research, Basel, Switzerland

Blocking vascular endothelial growth factor (VEGF) signaling has been validated as an effective approach for cancer therapy. VEGF overexpression in tumors is typically associated with increased angiogenesis and a poorer patient prognosis [1]. Recently, monitoring VEGF expression in human ovarian tumor xenografts has been achieved by utilizing the 89Zr-labelled anti-VEGF mAb bevacizumab as a PET probe [2]. Unfortunately, the use of 89Zr-mAbs may not be amenable for routine imaging of VEGF levels due to their long plasma half-life and the length of time required to achieve maximum contrast. Additionally, since the VEGF levels may be rapidly changing, a quick readout is often advantageous for diagnostic purposes. PET probes based on 18F-labeled peptides are more facile imaging agents because their faster plasma clearance allows optimal contrast within a few hours, facilitating repeated daily imaging. Target specific 18F-peptides have been obtained by combinatorial drug discovery methods combined with high throughput PET [3].

In this study we have utilized phage display technology to identify peptides that selectively recognize VEGF with nanomolar affinity. Two types of peptide-phage libraries were designed: one was based on three-helix Z-domain of staphylococcal protein A; the second library was based on the reengineered two-helix 39 residue “mini-Z” [4]. We report on the selection process, describe structural and biochemical characterization of the peptides selected, compare and contrast the image quality obtained from different peptides modified as PET probes and finally utilize a representative probe to investigate VEGF levels in a SKOV-3 ovarian cancer xenograph model. The PET images obtained with the peptide probe are comparable to those obtained using 89Zr-B20 (anti-VEGF mAb).

[1] Volm M et al., International Jnl Cancer 1997 74, 64

[2] Nagengast WB et al., J. Nucl. Med. 2007, 48, 1313

[3] Gagnon MKJ et al., PNAS 2009, 106, 17904

[4] Braisted AC and Wells JA PNAS, 93, 5658


Extended Abstract: File Not Uploaded
See more of this Session: Session 7: Biomolecular Probes as Diagnostic and Therapeutic Reagents
See more of this Group/Topical: General Submissions